Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Russell

Showing results (141-150 of 163) with videos related to

Pageof 17
Sort By:
World Journal of Surgery|September 27, 2001
Genetic markers of survival and liver recurrence after resection of liver metastases from colorectal cancerP J Crowe, J L Yang, C R Berney, et al.
Journal of Medicinal Chemistry|November 12, 1993
Preparation, characterization, cytotoxicity, and mutagenicity of a pair of enantiomeric platinum(II) complexes with the potential to bind enantioselectively to DNAK Vickery, A M Bonin, R R Fenton, et al.
Urologic Oncology|January 13, 2011
The prognostic significance of tumor-associated markers p53, HER-2/neu, c-myc, v-H-ras, PCNA and EGFr of local and distant recurrence in localized human prostatic adenocarcinomaK T Ow, H Mameghan, A Lochhead, et al.
Urological Research|January 1, 1991
Growth and metastasis of human bladder cancer xenografts in the bladder of nude rats. A model for intravesical radioimmunotherapyP J Russell, I Ho Shon, G R Boniface, et al.
American Journal of Public Health|September 1, 1986
Affirmative action at work: a survey of graduates of the University of California, San Diego, Medical SchoolN E Penn, P J Russell, H J Simon, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 11, 2000
Paraffin section storage and immunohistochemistry. Effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigenK Wester, E Wahlund, C Sundström, et al.
Journal of Medicinal Chemistry|March 28, 1997
Preparation, DNA binding, and in vitro cytotoxicity of a pair of enantiomeric platinum(II) complexes, [(R)- and (S)-3-aminohexahydroazepine]dichloroplatinum(II). Crystal structure of the S enantiomerR R Fenton, W J Easdale, H M Er, et al.
British Journal of Cancer|August 26, 2010
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progressionJ Hao, H Chen, M C Madigan, et al.
International Journal of Cancer|September 29, 2000
Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targetsJ L Yang, D q Seetoo, Y Wang, et al.
Cancer Research|April 1, 1986
Bladder cancer xenografts: a model of tumor cell heterogeneityP J Russell, D Raghavan, P Gregory, et al.
Pageof 17

Showing results (141-150 of 163) with videos related to

Sort By:
Pageof 17
World Journal of Surgery|September 27, 2001
Genetic markers of survival and liver recurrence after resection of liver metastases from colorectal cancerP J Crowe, J L Yang, C R Berney, et al.
Journal of Medicinal Chemistry|November 12, 1993
Preparation, characterization, cytotoxicity, and mutagenicity of a pair of enantiomeric platinum(II) complexes with the potential to bind enantioselectively to DNAK Vickery, A M Bonin, R R Fenton, et al.
Urologic Oncology|January 13, 2011
The prognostic significance of tumor-associated markers p53, HER-2/neu, c-myc, v-H-ras, PCNA and EGFr of local and distant recurrence in localized human prostatic adenocarcinomaK T Ow, H Mameghan, A Lochhead, et al.
Urological Research|January 1, 1991
Growth and metastasis of human bladder cancer xenografts in the bladder of nude rats. A model for intravesical radioimmunotherapyP J Russell, I Ho Shon, G R Boniface, et al.
American Journal of Public Health|September 1, 1986
Affirmative action at work: a survey of graduates of the University of California, San Diego, Medical SchoolN E Penn, P J Russell, H J Simon, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 11, 2000
Paraffin section storage and immunohistochemistry. Effects of time, temperature, fixation, and retrieval protocol with emphasis on p53 protein and MIB1 antigenK Wester, E Wahlund, C Sundström, et al.
Journal of Medicinal Chemistry|March 28, 1997
Preparation, DNA binding, and in vitro cytotoxicity of a pair of enantiomeric platinum(II) complexes, [(R)- and (S)-3-aminohexahydroazepine]dichloroplatinum(II). Crystal structure of the S enantiomerR R Fenton, W J Easdale, H M Er, et al.
British Journal of Cancer|August 26, 2010
Co-expression of CD147 (EMMPRIN), CD44v3-10, MDR1 and monocarboxylate transporters is associated with prostate cancer drug resistance and progressionJ Hao, H Chen, M C Madigan, et al.
International Journal of Cancer|September 29, 2000
Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targetsJ L Yang, D q Seetoo, Y Wang, et al.
Cancer Research|April 1, 1986
Bladder cancer xenografts: a model of tumor cell heterogeneityP J Russell, D Raghavan, P Gregory, et al.
Pageof 17